You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Descemet membrane endothelial keratoplasty

Showing 1 - 25 of 5,339
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Corneal Dystrophies, Hereditary Trial in Rotterdam (Descemet Membrane Endothelial Keratoplasty (DMEK))

Completed
  • Corneal Dystrophies, Hereditary
  • Descemet Membrane Endothelial Keratoplasty (DMEK)
  • Rotterdam, Netherlands
    Netherlands Institute for Innovative Ocular Surgery
Jan 11, 2023

Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy Trial (DSAEK, DMEK)

Not yet recruiting
  • Corneal Edema
  • +4 more
  • DSAEK
  • DMEK
  • (no location specified)
Jun 29, 2022

Fuchs' Endothelial Dystrophy Trial in Freiburg (Supine positioning: 5 days, Supine positioning: 1 days)

Not yet recruiting
  • Fuchs' Endothelial Dystrophy
  • Supine positioning: 5 days
  • Supine positioning: 1 days
  • Freiburg, Baden-Wuerttemberg, Germany
    Medical Center - University of Freiburg, Eye Hospital
May 31, 2022

DMEK Endothelial Keratoplasty inHistory of Anterior or Posterior

Not yet recruiting
  • Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
  • Descemet Membrane Endothelial Keratoplasty
  • (no location specified)
Aug 22, 2023

Corneal Endothelial Decompensation, Fuchs' Endothelial Dystrophy Trial in Indianapolis, Grand Rapids (Descemet membrane

Recruiting
  • Corneal Endothelial Decompensation
  • Fuchs' Endothelial Dystrophy
  • Descemet membrane endothelial keratoplasty
  • Indianapolis, Indiana
  • +1 more
Oct 3, 2022

Fuchs Endothelial Dystrophy Trial in Portland (Glanatec, Optive, Ophthalmic Solution, Descemet Membrane Endothelial

Recruiting
  • Fuchs Endothelial Dystrophy
  • Portland, Oregon
    Devers Eye Institute
Sep 2, 2021

Corneal Endothelial Dystrophy, Corneal Edema Trial in Indianapolis (loteprednol etabonate 0.25% ophthalmic suspension)

Active, not recruiting
  • Corneal Endothelial Dystrophy
  • Corneal Edema
  • loteprednol etabonate 0.25% ophthalmic suspension
  • Indianapolis, Indiana
    Price Vision Group
Jan 6, 2023

Descemet Membrane Endothelial Keratoplasty vs. Descemet's

Recruiting
  • Cystoid Macular Edema
  • Fuchs Dystrophy
  • Optical Coherence Tomography
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Dec 16, 2021

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) Trial

Recruiting
  • Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
  • Descemet Membrane Endothelial Keratoplasty (DMEK)
  • Nepafenac Ophthalmic
  • Dexamethasone Ophthalmic
  • Oslo, Norway
    Department of Ophthalmology, Oslo University Hospital
Nov 26, 2022

Fuchs' Endothelial Dystrophy Trial in Vienna (Ultrahigh resolution Spectral Domain OCT)

Completed
  • Fuchs' Endothelial Dystrophy
  • Ultrahigh resolution Spectral Domain OCT
  • Vienna, Austria
  • +1 more
Apr 6, 2022

Corneal Endothelial Cell Loss, Fuchs' Endothelial Dystrophy Trial in Terrassa (Descemet Stripping Automated Endothelial

Completed
  • Corneal Endothelial Cell Loss
  • Fuchs' Endothelial Dystrophy
  • Descemet Stripping Automated Endothelial Keratoplasty
  • Descemet Membrane Endothelial Keratoplasty
  • Terrassa, Barcelona, Spain
    Hospital Universitari Mutua Terrassa
Mar 9, 2021

Pseudophakic Bullous Keratopathy, Anterior Chamber Intraocular Lens Trial in Alexandria (Descemet membrane endothelial

Unknown status
  • Pseudophakic Bullous Keratopathy
  • Anterior Chamber Intraocular Lens
  • Descemet membrane endothelial keratoplasty DMEK
  • +3 more
  • Alexandria, Egypt
    Faculty of Medicine
Aug 10, 2020

After Primary Descemet's Membrane Endothelial Keratoplasty

Completed
  • Endothelial Corneal Dystrophy
    • (no location specified)
    Jul 9, 2020

    Keratoplasty, Grafting, Corneal, Transplantation, Corneal Trial in Palo Alto, San Francisco, Portland (procedure, device, drug)

    Active, not recruiting
    Has Results
    • Keratoplasty
    • +4 more
    • DSAEK
    • +7 more
    • Palo Alto, California
    • +2 more
    Nov 19, 2020

    Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases Trial in London (QR-504a)

    Withdrawn
    • Fuchs Endothelial Corneal Dystrophy
    • +4 more
    • London, United Kingdom
      Moorfields Eye Hospital, NIHR Clinical Research Facility
    May 5, 2022

    Fuchs' Endothelial Dystrophy, Bullous Keratopathy Trial in Glostrup (Intraocular gas)

    Unknown status
    • Fuchs' Endothelial Dystrophy
    • Bullous Keratopathy
    • Intraocular gas
    • Glostrup, Denmark
      Glostrup Hospital, University of Copenhagen
    Feb 14, 2019

    Fuchs' Endothelial Dystrophy Trial in Glenview (Ripasudil HCl hydrate 0.4% ophthalmic solution)

    Recruiting
    • Fuchs' Endothelial Dystrophy
    • Ripasudil hydrochloride hydrate 0.4% ophthalmic solution
    • Glenview, Illinois
      NorthShore University HealthSystem
    Aug 9, 2021

    Fuchs' Endothelial Dystrophy Trial in Indianapolis (Netarsudil, Placebo)

    Terminated
    • Fuchs' Endothelial Dystrophy
    • Indianapolis, Indiana
      Price Vision Group
    Aug 28, 2021

    Descemet's Stripping Automated Endothelial Keratoplasty

    Completed
    Has Results
    • Corneal Edema Secondary to Corneal Endothelial Dystrophy
    • DSAEK
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center - Aston Ambulatory Clinic
    Nov 17, 2020

    Fuchs' Endothelial Corneal Dystrophy, Bullous Keratopathy, Iridocorneal Endothelial Syndrome Trial in Indianapolis (endothelial

    Completed
    • Fuchs' Endothelial Corneal Dystrophy
    • +3 more
    • endothelial keratoplasty
    • Indianapolis, Indiana
      Price Vision Group
    Jan 21, 2019

    OCT in Fuchs' Dystrophy

    Recruiting
    • Fuchs Dystrophy
    • Pseudophakic Bullous Keratopathy
      • Portland, Oregon
        Oregon Health & Science University
      Sep 21, 2021

      Fuchs Trial in United States (Topical Ripasudil, Topical Placebo)

      Recruiting
      • Fuchs
      • Topical Ripasudil
      • Topical Placebo
      • Palo Alto, California
      • +3 more
      Jan 18, 2023

      Fuchs' Endothelial Dystrophy, Cataract Trial in Boston (Netarsudil 0.02% Ophthalmic Solution)

      Completed
      • Fuchs' Endothelial Dystrophy
      • Cataract
      • Netarsudil 0.02% Ophthalmic Solution
      • Boston, Massachusetts
        Massachusetts Eye and Ear Infirmary
      Jan 24, 2021

      Congenital Hereditary Endothelial Dystrophy of Cornea Trial in Hyderabad (Nepafenac 0.1% Oph Susp, Refresh Tears 0.5% Lubricant

      Recruiting
      • Congenital Hereditary Endothelial Dystrophy of Cornea
      • Nepafenac 0.1% Oph Susp
      • Refresh Tears 0.5% Lubricant Eye Drops
      • Hyderabad, Banjara Hills, India
        L V Prasad Eye Institute
      Apr 8, 2021

      Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,

      Not yet recruiting
      • Pseudophakic Bullous Keratopathy
      • +2 more
      • Fluorometholone 0.1% Oph Susp
      • +2 more
      • (no location specified)
      Feb 7, 2023